Cabergoline
| CAS No. | 81409-90-7 | Cat. No. | BCP09384 |
| Name | Cabergoline | ||
| Synonyms | n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-ergoline-8-carboxamid;FCE-21336,Cabaser,Dostinex;(8b)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)- ergoline-8-carboxam; | ||
| Formula | C26H37N5O2 | M. Wt | 451.6 |
| Description | Cabergoline is a selective D2DR (D2-like receptor) agonist, similarly displaying a high affinity for several serotonin receptor subtypes. Cabergoline exhibits an inhibitory effect of the secretion of prolactin and growth hormone and has been shown to reverse levodopa-induced dyskinesias in Parkinsonian monkeys. Cabergoline is an activator of D3DR. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Dopamine Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.